Currently, there are 253.96M common shares owned by the public and among those 249.51M shares have been available to trade.
The company’s stock has a 5-day price change of 0.61% and -6.48% over the past three months. MTCH shares are trading -9.45% year to date (YTD), with the 12-month market performance up to 2.96% higher. It has a 12-month low price of $27.66 and touched a high of $42.42 over the same period. MTCH has an average intraday trading volume of 4.26 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.41%, -5.09%, and -2.46% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Match Group Inc (NASDAQ: MTCH) shares accounts for 106.87% of the company’s 253.96M shares outstanding.
It has a market capitalization of $8.30B and a beta (3y monthly) value of 1.27. The stock’s trailing 12-month PE ratio is 14.74, while the earnings-per-share (ttm) stands at $2.24. The company has a PEG of 0.62 and a Quick Ratio of 2.49. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.77% over the week and 2.82% over the month.
Earnings per share for the fiscal year are expected to decrease by -12.47%, and 16.34% over the next financial year. EPS should grow at an annualized rate of 23.92% over the next five years, compared to 7.04% over the past 5-year period.
HSBC Securities coverage for the Match Group Inc (MTCH) stock in a research note released on August 05, 2024 offered a Buy rating with a price target of $43.20. Wolfe Research was of a view on July 16, 2024 that the stock is Outperform, while Citigroup gave the stock Neutral rating on July 15, 2024, issuing a price target of $34- $33. Morgan Stanley on their part issued Equal-Weight rating on April 18, 2024.
